Search the Newsreel

Canopy Growth’s Kincardine Facility Secures EU-GMP Recertification

Canopy Growth's Kincardine, Ontario facility has received renewed EU-GMP certification from a German authority, critical for exporting medical cannabis to Germany. This recertification highlights the facility's quality and reliability, supporting Canopy Growth's expanding presence in the European market. The Kincardine facility, a 440,000-square-foot greenhouse, …

Canopy Growth renews EU certification for Ontario facility

Canopy Growth Corporation announced the renewal of its European Union Good Manufacturing Practice (EU GMP) certification for its Kincardine, Ontario cultivation facility. This certification allows the company to continue supplying Canadian-grown medical cannabis to European markets. The renewal reflects the quality of their cultivation …

Canopy Growth Can Keep Supplying Canadian-Grown Medical Cannabis Across Europe

Canopy Growth Corporation announced its Kincardine, Ontario facility received renewed EU GMP certification, allowing it to continue supplying Canadian-grown medical cannabis to European markets. This renewal underscores the quality of its cultivation operations and supports the company's growing European business, which contributed to a …

Canopy Growth Secures Renewed EU GMP Certification at Kincardine as European Medical Cannabis Business Grows

Canopy Growth Corporation announced its Kincardine, Ontario facility has received renewed EU GMP certification, allowing it to continue supplying Canadian-grown cannabis to European medical markets. This renewal underscores the quality of their cultivation operations and supports the company's expanding European business, which contributed to …

Oppenheimer (OPY) Earnings Date and Reports 2026 $OPY

Walmart Downgraded Ahead Of Earnings This Month – Oppenheimer Sees A ‘Less Compelling Outperformance Case’

Is Oppenheimer Holdings (OPY) Fully Valued Following Strong Q2 Earnings?

Canopy Growth Stock Extends Green Momentum as Revenue Growth and Margin Recovery Lift Investor Optimism

Earnings Release: Here's Why Analysts Cut Their Canopy Growth Corporation (TSE:WEED) Price Target To CA$2.02

Canopy Growth Corporation (NASDAQ:CGC) Given Consensus Recommendation of "Hold" by Analysts

Canopy Growth Corporation (NASDAQ:CGC) has received a consensus "Hold" rating from analysts, with two firms recommending a buy, two a hold, and one a sell. The company recently reported better-than-expected quarterly results, with a loss of $0.02 per share against an anticipated $0.04 loss, …

Why (OPY) Price Action Is Critical for Tactical Trading

This article from Stock Traders Daily discusses the critical price action of Oppenheimer Holdings Inc. (NYSE: OPY) for tactical trading. It highlights a weak near-term sentiment but strong mid and long-term outlooks, presenting an exceptional risk-reward setup. The analysis provides AI-generated signals and three …

Canopy Growth Targets European Cannabis Expansion After MTL Deal and Cost Cuts

Canopy Growth (NASDAQ:CGC) is strategically refocusing on consumer cannabis, particularly in European markets and Canadian recreational cannabis, after significant restructuring, cost reductions, and the acquisition of MTL Cannabis. The company has seen growth across its businesses, including 20% in Canadian adult-use cannabis and 10% …

Canopy Growth Corporation (TSX:WEED) Falls 3.65% as Cannabis Sector Uncertainty and Profitability Concerns Pressure Shares

Canopy Growth: Penny Stock Purgatory -- or Cannabis Rebound in the Making?

Canopy Growth (NASDAQ: CGC) has spent the better part of the past five years destroying shareholder value. The stock is down more than 99% from its all-time high. The company has burned through billions of dollars, diluted shareholders repeatedly, exited non-core businesses, and cycled …

BofA, JPMorgan, Oppenheimer Name Their 3 Favorite AI Stocks, One Has a $255 Target

Canopy Growth reports fiscal first quarter revenue growth, improved margins

Canopy Growth Corporation reported a 13% year-over-year revenue increase to C$81.2 million in its fiscal first quarter of 2027, surpassing analyst estimates. The cannabis company also significantly narrowed its adjusted EBITDA loss by 59% to C$3.2 million, driven by revenue growth across all business …

Why Rescheduling Might Not Move Canopy Growth's Stock as Much as You Think

Key Points The United States is slowly moving toward the legalization of marijuana. The next big step is the rescheduling of the drug at the federal level, which won't make it legal, just less illegal. Canopy Growth's business won't be dramatically impacted either way.10 …

Canopy Growth posts 13% revenue rise and narrows losses in Q1 fiscal 2027, shares up 5%.

Canopy Growth Corporation reported a 13% increase in net revenue to C$81.2 million for the first quarter of fiscal 2027, exceeding analyst estimates. The company significantly narrowed its adjusted EBITDA losses by 59% to C$3.2 million and reduced its net loss by 68% year-over-year. …

Canopy Growth Q1 Earnings Call Highlights

Canopy Growth (NASDAQ: CGC) reported a 13% increase in Q1 fiscal 2027 net revenue to C$81.2 million, driven by growth in its cannabis and Storz & Bickel businesses. The company narrowed its adjusted EBITDA loss by 59% to C$3.2 million and aims for positive …

Canopy Growth (NASDAQ:CGC) Stock Rating Upgraded by Wall Street Zen

Canopy Growth (NASDAQ:CGC) Announces Quarterly Earnings Results

Canopy Growth (NASDAQ:CGC) reported stronger-than-expected quarterly earnings, with revenue up 13% year-over-year to C$81.2 million and a narrowed loss of C$0.02 per share, surpassing analyst estimates. The company showed improved adjusted gross margins and a reduced adjusted EBITDA loss, targeting positive adjusted EBITDA in …

Canopy Growth (Nasdaq: CGC) lifts Q1 sales 13%, cuts loss 68%

Canopy Growth Corporation reported a 13% increase in Q1 FY2027 net revenue to $81.165 million, driven by strong growth in both cannabis and Storz & Bickel segments. The company significantly narrowed its net loss by 68% to $14.579 million and improved Adjusted EBITDA loss …

Canopy Growth Corp SEC Filing (Aug 7, 2026)

This article reports on an SEC filing (Form ARS) by Canopy Growth Corp (CGC) on August 7, 2026. The filing had a low impact and neutral sentiment, according to AI-generated analysis. The article provides details on the filing, including its acceptance by SEC EDGAR …

Canopy Growth 1Q Rev C$81.2M >WEED.T

Canopy Growth (WEED.T) reported its first-quarter revenue, reaching C$81.2 million. This financial update provides key insights into the company's performance during the quarter. The >WEED.T symbol indicates its listing on the Toronto Stock Exchange.

Canopy Growth Sees Steady Progress on Profitability Measures

Stocks in play: Canopy Growth Corporation

Canopy Growth Corporation (WEED.TO, CGC) announced its financial results for the first quarter of fiscal year 2027. The company reported a 13% increase in consolidated net revenue to $81.2 million compared to the same period in the previous year, and a 68% lower net …

Canopy Growth Narrows Adjusted EBITDA Loss 59% to $3.2M

Canopy Growth Corporation reported its Q1 FY2027 financial results, showing a 13% increase in consolidated net revenue to $81.2 million, with growth across all business segments. The company significantly narrowed its Adjusted EBITDA loss by 59% year-over-year to $3.2 million, attributed to revenue growth …

Canopy Growth Corporation (CGC) Reports Q1 Loss, Tops Revenue Estimates

Canopy Growth Corporation (CGC) reported a Q1 loss of $0.02 per share, outperforming the Zacks Consensus Estimate of a $0.04 loss, and revenue of $58.63 million, slightly exceeding estimates. Despite this, the company's shares have fallen 18.2% year-to-date, contrasting with the S&P 500's gain. …

Oppenheimer reiterates Tandem Diabetes stock rating on pharmacy gains

Form 8K Canopy Growth Corp For: 7 August By Investing.com

This article announces the filing of a

Canopy Growth (CGC) Tops Q1 EPS by 3c

Canopy Growth (CGC) reported better-than-expected Q1 earnings, with an EPS of Cdn$0.03, surpassing analyst estimates by Cdn$0.03. The company also exceeded revenue expectations, bringing in Cdn$81.2 million against a consensus estimate of Cdn$58.89 million.

Canopy Growth (NASDAQ: CGC) trims loss, outlines Acreage debt risk

Canopy Growth to Report First Quarter Fiscal 2027 Financial Results on August 7, 2026

Canopy Growth Corporation (TSX: WEED, Nasdaq: CGC) announced it will release its financial results for the first quarter fiscal year 2027, which ended June 30, 2026, before financial markets open on August 7, 2026. The company will host an audio webcast with CEO Luc …